Last updated: 2021/10/22
Homepage
Last updated: 2021/10/22
- Fight Against Covid-19
- Products
- Fight Against Covid-19
- Medical Devices
- Peripheral Interventional Products
- Cardiovascular Products
- Neurointerventional Products
- Digital Subtraction Angiography System
- Structural Heart Diseases Products
- Cardiac Rhythm Management Products
- ECG & Patient Monitor & Oximeter
- Home Medical Equipment
- Critical Care Products
- Hemodialysis
- In Vitro Diagnostics
- Surgical Products
- Ultrasound
- Oncology Diagnostics
- Orthopedic Products
- Ortho-Bridge System
- Trauma Implant
- Interlocking Intramedullary Nails System
- Locking Compression Plates System
- Clavicle
- Humerus
- Ulna & Radius
- LC-LCP (III) (Ulna, Radius), Combined-lock
- Dorsal Proximal Ulnar Locking Plate, Combined-lock
- Volar Distal Radius Locking Plate (I), Combined-lock
- Variable Angle Volar Rim Distal Radius Locking Plate, Combined-lock
- Volar Distal Radius Locking Plate (V), Combined-lock
- Dorsal Distal Radius Locking Plate (L shape), Combined-lock
- Volar Distal Radius Locking Plate (Oblique), Combined-lock
- Dorsal Distal Radius Locking Plate, Combined-lock
- Volar Distal Radius Locking Plate (II), Combined-lock
- Femur
- Tibia & Fibula
- Locking Plates
- Mini Plates System
- 1.5 mm Straight Locking Compression Plate
- 1.5 mm Condylar Locking Plate
- 1.5 mm Rotary Straightening Locking Plate, Combined-lock
- 1.5 mm Straight Locking Plate
- 1.5 mm T-shape Locking Plate
- 1.5 mm T-shape Finger (Metatarsal) Locking Plate (I)
- 1.5 mm Y-shape Finger (Metatarsal) Locking Plate
- 1.5 mm Buttress Locking Plate
- 2.0 mm T-shape Locking Plate, Combined-lock
- 2.0 mm T-shape Anotomic Locking Plate, Combined-lock
- 2.0 mm Y-shape Locking Plate, Combined-lock
- 2.0 mm Condylar Locking Plate, Combined-lock
- 2.0 mm Rotary Straightening Locking Plate, Combined-lock
- 2.4 mm T-shape Locking Plate, Combined-lock
- 2.4 mm T-shape Anotomic Locking Plate, Combined-lock
- 2.4 mm Y-shape Locking Plate, Combined-lock
- 2.4 mm Condylar Locking Plate, Combined-lock
- 2.7 mm Condylar Locking Plate, Combined-lock
- 2.7 mm T-shape Locking Plate, Combined-lock
- 2.7 mm L-shape Locking Plate, Combined-lock
- 2.7 mm L-shape Locking Plate (Oblique), Combined-lock
- 2.7 mm Double Orifice Locking Plate
- 2.7 mm X-shape Locking Plate
- 2.7 mm H-shape Extended Locking Plate
- Conventional Plates
- Patellar Rings
- Screws
- Metal Pins
- Dynamic Hip Locking Plate
- Spinal Implant
- Joint Replacement Implant
- Surgical Instruments
- About Newton Lab
- Pharmaceutical (API)
- About Us
- Events & News
- News
- Announcement of unauthorized self-testing Antigen test kit
- ILAC Review: Techniques and Experiences in Aneurysm Coiling
- Statement of Unauthorized Documents with Counterfeit Stamps of Lepu
- Why Early Cancer Diagnosis Matter?
- Lepu Medical Contributes to Global Pandemic Effort by Hosting International Seminar on COVID-19 Detection Methods
- Lepu Presents Structural Heart Diseases Solutions on EuroPCR
- ANNOUNCEMENT: Scam and Fake Websites Alert
- Lepu Perfiller® Expansible Embolic Coil System Acquires CE Approval
- Lepu launches AI-powered Neo ECG tablet
- Guaranteed safety and effectiveness of Lepu SARS-CoV-2 Antigen Rapid test
- Want a healthy, strong heart? Try to lose weight and keep nutrition from now!
- Lepu Medical’s SARS-CoV-2 Antigen Rapid Test Kit Attained CE Certificate for Covid-19 Self-Test
- Cerebral Aneurysm, A Bomb in Your Brain
- Lepu Medical Cardiovascular Devices Attain Marketing Authorization in Saudi Arabia
- Lepu Medical Sterile Syringe Wins CE Mark Approval for General Use, COVID-19 Vaccines
- End-Stage Renal Disease (ESRD): Symptoms, Treatment, and More
- How Do I Know My Vaccine is Effective?
- Upcoming Event: Neurointervention Beyond Borders: Techniques and Experiences in Aneurysm Coiling
- Lepu Medical Releases 2021 Interim Report
- Lepu Medical Co-Hosts International Seminar to Share Insights on Neurointervention
- Lepu Medical's POCT Solution Receives IVDR Certificate
- Statement on Unauthorized Release of LEPU COVID-19 Relevant Products Information
- Professional Cooperation And Techniques For Lepu Medical In Neuro Interventional Markets
- Memopart™ PDA Occluder Successfully Rescued Children With Complex Congenital Heart In Pakistan
- Notice On Acceptation Of Medical Device Registration For Bioabsorbable Drug-eluting (rapamycin) Stent System
- Lepu Medical Expected Net Profit Of First Half Of 2017 To Be 528 Million Cny (79 Million Usd), Year-on-year Growth Reached Up To 40%
- Lepu: fight against covid-19 together, corporate with Austrian Federal Ministry of Education, Science and Research, five million antigen tests for schools.
- Are Coronary Stents Really Useful?
- What Are the Types of Catheters?
- Introduction to the Properties and Materials of Catheters
- Angiographic Catheter with Precise Control
- The Thicker the Thrombus Aspiration Catheter, The Higher the Success Rate of Thrombectomy?
- Considering coronary stents? Here are the facts you must know!
- Matters Needing Attention When Using ECG Monitor
- The Procedure and Object of Using ECG Monitor
- Lepu Infrared Forehead Thermometers receive FDA Approval
- Why Develop a COVID-19 Antigen Test Kit?
- Infrared Thermometer Has Become a Hot-selling Product for Epidemic Prevention
- Who Would Dare to Say That the Colloidal Gold Quick Inspection Product is Outdated After COVID-19?
- What Are the Types of Angiographic Catheters?
- Discussion on Anti-electrosurgical Interference Methods for ECG Monitor
- 04.20.2021: Announcement of unauthrorized self-testing Antigen test kit
- Explore Lepu Products in Your Language
- Can an Oxygen Generator Replace a Ventilator during COVID-19 Outbreak?
- The Working Principle of Atrial Septal Occluder and Its Characteristics for BPF Treatment
- The Choice and Blocking Method of Atrial Septal Occluder
- Precautions After Coronary Stent Surgery
- Application and Classification of Left Atrial Appendage Occluder
- Statement on Shipping of Future Cargo to the Americas and Other Regions
- New Materials and New Technologies Give New Possibilities for PCI Surgery
- The Introduction of PTCA Guide Wire Core
- Features and Basic Configurations of PTCA Wire
- Do We Need to Prepare an Oximeter at Home During the COVID-19 Pandemic?
- The COVID-19 Changes the Consumption Habits of Testing Products, and the Market Space of the POCT Industry Has Been Significantly Higher Than Expected
- The most dangerous cardiovascular disease? Facts about coronary artery disease (CAD)
- Smooth Coating of PTCA Wire
- PTCA Guide Wire for Coronary Intervention
- Letter of Declaration
- Basic Knowledge about POCT Test
- What Are the Applicable Groups of Lepu Medical Oximeter?
- Development of Global Point-of-care Testing (POCT)
- What is an Embolic Coil?
- Coil Embolization and Postoperative Treatment
- Classification, Composition and Application Scope of Single-use Syringes
- How to Evaluate Patients With Preoperatively Implanted Coronary Stents for Non-cardiac Surgery?
- Regulations on Disposal and Classification of Single-use Syringes
- How Effective is the AI-based ECG Algorithm for Detection of Clinical Arrhythmia?
- Types of Lepu Coronary Artery Stents
- Events
- Investors
- Announcements
- Temporary Announcements
- Announcement on Progress in Repurchasing Company Shares
- 2019 Semi-Annual Report Reveals Informative Announcement
- Pre-Disclosure Reminder Announcement on Shareholders Holding More Than 5％ of Shares
- Announcement on Progress in Repurchasing Company Shares1
- Announcement on the progress of investment in Liaoning Boao Biopharmaceutical Co., Ltd.
- Legal Opinion Of Lepu Medical's First Extraordinary Shareholder Meeting In 2019
- Announcement of Resolutions of the First Extraordinary Shareholders' General Meeting in 2019
- Announcement on Receiving the Notice of Resumption Review of the Administrative License Application of the China Securities Regulatory Commission
- Lepu Medical: Announcement on Participating in a Group Reception Day for Investors in Listed Companies in Shenzhen and Beijing
- Lepu Medical: Announcement on Receiving Notification of Administrative Licensing Resumption Review of China Securities Regulatory Commission
- Lepu Medical: 2019 Semiannual Results Preview
- Lepu Medical: Announcement of Resolutions of the 23rd Meeting of the Fourth Board of Directors
- Lepu Medical: Announcement of Resolutions of the 22nd Meeting of the 4th Supervisory Board
- Lepu Medical: Announcement on Partial Equity Pledge of Controlling Shareholders and Release of Pledge
- Lepu Medical: Announcement on Providing Guarantee for the Holding Subsidiary Zhejiang Lepu Pharmaceutical Co., Ltd.
- Lepu Medical: Notice on Holding the First Extraordinary Shareholders' Meeting in 2019
- Lepu Medical: Announcement on the progress of repurchasing company shares
- Lepu Medical: Announcement of Resolutions of the 22nd Meeting of the 4th Board of Directors
- Lepu Medical: Announcement of Resolutions of the 21st Meeting of the Fourth Supervisory Board
- Lepu Medical: Independent Director's Independent Opinion on the Appointment of the Deputy General Manager
- Lepu Medical: Announcement on the Company's Application for a Comprehensive Credit Line from a Bank
- Lepu Medical: Announcement on Appointing Deputy General Manager of the Company
- Lepu Medical: Announcement on Applying for M
- Lepu Medical: Prompt Announcement on the Application of Insulin Glargine and Insulin Glargine Injection for Pharmaceutical Production Application
- Lepu Medical: Announcement on the Acceptance of NMPA Registration Application for Artificial Intelligence ECG Machine
- Lepu Medical: Announcement on the Acceptance of CFDA Registration Application for Endovascular Drug (Paclitaxel) Eluted Balloon Catheter (Coronary Artery)
- Lepu Medical: Announcement on Senior Deputy General Manager and Secretary of the Board Increasing Shares in the Company
- Lepu Medical: Informative Announcement for the First Quarter Report of 2019
- Lepu Medical: Announcement of Resolutions of the 21st Meeting of the Fourth Board of Directors
- Lepu Medical: Announcement of Resolutions of the 20th Meeting of the Fourth Supervisory Board
- Lepu Medical: Independent Director's Independent Opinion on Changes in Accounting Policies
- Lepu Medical: Announcement on Changes in Accounting Policies
- Lepu Medical: Announcement on Providing Guarantee for Whollyowned Subsidiary Lepu Pharmaceutical Co., Ltd.
- Lepu Medical: Legal Opinions of the 2018 Annual Shareholders' Meeting
- Lepu Medical: Announcement of Resolutions of the 2018 Annual General Meeting of Shareholders
- Lepu Medical: Announcement of the Issuance of the First Phase of Ultra-short-term Financing Bonds in 2019
- Lepu Medical: 2018 Work Report of the Supervisory Board
- Lepu Medical: 2018 Internal Control Self-evaluation Report
- Lepu Medical: 2018 Social Responsibility Report
- Lepu Medical: Informative Announcement of 2018 Annual Report Disclosure
- Lepu Medical: Preview of First Quarter 2019 Results
- Lepu Medical: Announcement of Resolutions of the 20th Meeting of the Fourth Board of Directors
- Lepu Medical: Announcement of Resolutions of the 19th Meeting of the 4th Supervisory Board
- Haitong Securities Co., Ltd.'s semi-annual tracking report for 2019
- Lepu Medical: Announcement of Public Road Issuance of Convertible Corporate Bonds Online Roadshow
- Lepu Medical: Prompt Announcement on Public Offering of Convertible Corporate Bonds Prospectus
- Lepu Medical: Public Issuance of Convertible Corporate Bond Issuance Announcement
- Lepu Medical: Announcement of Resolutions of the 29th Meeting of the Fourth Board of Directors
- Lepu Medical: GEM's Public Offering of Convertible Corporate Bonds Prospectus Summary
- Lepu Medical: GEM Public Offering of Convertible Corporate Bonds Prospectus
- Lepu Medical: Beijing Zhonglun Law Firm's Work Report on Lawyers'Public Offering of Convertible Corporate Bonds
- Lepu Medical: Beijing Zhonglun Law Firm's Legal Opinion on Public Offering of Convertible Corporate Bonds by GEM
- Lepu Medical Beijing Zhonglun Law Firms Supplementary Legal Opinion on the Public Issuance of Convertible Corporate Bonds by the Companys Growth Enterprise Market (4)
- Lepu Medical: Beijing Zhonglun Law Firm's Supplementary Legal Opinion on the Public Issuance of Convertible Corporate Bonds by the Company's Growth Enterprise Market (3)
- Lepu Medical: Beijing Zhonglun Law Firm's Supplementary Legal Opinion on the Public Issuance of Convertible Corporate Bonds by the Company's Growth Enterprise Market (2)
- Lepu Medical: Beijing Zhonglun Law Firm' s Supplementary Legal Opinion on the Public Issuance of Convertible Corporate Bonds by the Company' s Growth Enterprise Market (5)
- Lepu Medical: Beijing Zhonglun Law Firm' s Supplementary Legal Opinion on the Public Issuance of Convertible Corporate Bonds by the Company' s Growth Enterprise Market 1
- Lepu Medical: Announcement on the Completion of the First Payment of the Ultra Short-Term Financing Bonds in 2019
- Lepu Medical: Announcement on the Public Issuance of Convertible Corporate Bonds Approved by the China Securities Regulatory Commission1
- Lepu Medical: Announcement on Adjustment of Share Repurchase Program
- Lepu Medical: Announcement on Expiry of Share Repurchase Term and Completion of Repurchase
- Lepu Medical: Announcement on the Progress of Shareholders Holding More Than 5％ of Their Shares
- Lepu Medical: Independent Opinions of Independent Directors on Matters Related to the 28th Meeting of the Fourth Board of Directors
- Lepu Medical: Announcement of Resolutions of the 26th Meeting of the Fourth Supervisory Board
- Lepu Medical: Announcement of Resolutions of the 28th Meeting of the Fourth Board of Directors
- Lepu Medical: Announcement of General Election and Solicitation of Candidates for the Supervisory Board
- Lepu Medical: Announcement of Board Election and Solicitation of Candidates
- Lepu Medical: Announcement On The Completion Of The Payment Of The First Medium Term Bill In 2016
- Lepu Medical: Announcement of the Issuance of the Second Phase of Ultra-short-term Financing Bonds in 2019
- Lepu Medical: Announcement on Valsartan Capsules Passing Drug Consistency Evaluation
- Lepu Medical: Announcement on the Public Issuance Of Convertible Corporate Bonds Approved by the China Securities Regulatory Commission
- Lepu Medical: Announcement of Resolutions of the Third Extraordinary Shareholders' Meeting in 2019
- Lepu Medical: Legal Opinion of the Third Extraordinary Shareholders' Meeting in 2019
- Lepu Medical: Respond to the Letter of Preparation for the Meeting of the Board for the Issuance of Convertible Bonds Issued by the Company Publicly
- Announcement on the Conformity Evaluation of Amlodipine Besylate Tablets
- Foreign Exchange Hedging Business Management System
- Haitong Securities Co., Ltd.'s Verification Opinion on Lepu (Beijing) Medical Devices Co., Ltd.'s Foreign Exchange Hedging Business
- Independent Opinions of Independent Directors on Matters Related to the 27th Meeting of the Fourth Board of Directors of the Company
- 2019-095 2019 Third Quarter Report Disclosure Informative Announcement
- 2019-094 Notice Regarding the Convening of the Third Extraordinary General Meeting of 2019
- 2019-093 Announcement on Applying for a Loan from the Beijing Branch of China Development Bank
- 2019-092 Announcement on Changes in Accounting Policies
- 2019-090 Announcement on Providing Guarantee for Whollyowned Subsidiary Lepu Holdings Co., Ltd.
- 2019-089 Announcement On The Application Of A Foreign-owned Syndicated Loan By A Wholly-owned Subsidiary, Lepu Holdings Co., Ltd.
- 2019-087 Announcement of Resolutions of the 25th Meeting of the Fourth Supervisory Board
- 2019-086 Announcement of Resolutions of the 27th Meeting of the Fourth Board of Directors
- Reply To The Letter Requesting The Preparation Of The Meeting Of The Review Committee Of Lepu (beijing) Medical Devices Co., Ltd.
- 2019 First Three Quarter Results Forecast
- Announcement on Progress in Repurchasing Company Shares
- Notice on Convening the Second Extraordinary Shareholders' Meeting in 2019
- Announcement of Resolutions of the 26th Meeting of the Fourth Board of Directors
- Announcement on the Centralized Procurement of Clopidogrel Hydrogen Sulfate Tablets and Atorvastatin Calcium Tablets in Selected Regions of the Alliance
- Announcement on Changes in Accounting Policies
- Announcement on the Revision of the Public Offering of Convertible Corporate Bonds
- Announcement on the Risk Prompts for Dilutive Current Returns of Convertible Corporate Bonds and the Filling Measures (Second Revision)
- Public Issuance of Convertible Corporate Bonds (Second Revision)
- Demonstration and Analysis Report of Public Issuance of Convertible Corporate Bonds (Second Revision)
- Independent Opinions of Independent Directors on Issues Related to the 25th Meeting of the Fourth Board of Directors of the Company
- Announcement of Resolutions of the 24th Meeting of the Fourth Supervisory Board
- Announcement of Resolutions of the 25th Meeting of the Fourth Board of Directors
- Feasibility Report on the Use of Raised Funds (Second Revision)
- Lepu Medical: Beijing Zhonglun Law Firm's Supplementary Legal Opinion on the Public Issuance of Convertible Corporate Bonds by the Company's Growth Enterprise Market (2)
- Lepu Medical: Statement of Independent Director Nominee (2)
- Lepu Medical: Announcement on the Company's Application for Credit Lines with Banks
- Lepu Medical: 2019 Annual Results Express
- Lepu Medical: Announcement on the Implementation of the Shareholding Reduction Plan for Shareholders Holding More Than 5％
- Lepu Medical: Announcement on the Company's Application for a Credit Line from a Bank.PDF
- Lepu Medical: Announcement of Resolutions of the Second Meeting of the Fifth Board of Directors
- Lepu Medical: Announcement on the Approval of NMPA Registration for Artificial Intelligence
- Lepu Medical: Announcement on the Selection of New Coronavirus Nucleic Acid Testing Units in Beijing
- Lepu Medical: Announcement on the Approval of NMPA Registration for Two Medical Angiography X-Ray Machines
- Lepu Medical: 2019 Annual Results Preview
- Lepu Medical: Special Audit Report on Funds Replacement
- Lepu Medical: Haitong Securities Co., Ltd.'s Verification Opinions on the Company's Use of the Proceeds to Replace the Self-Funding Funds Invested in Projects Raised in Advance
- Lepu Medical: Announcement on the use of raised funds to replace self-raised funds previously invested in fundraising projects
- Lepu Medical: Announcement on the Acceptance of NMPA Registration Application for Cutting Balloon System
- Lepu Medical: Independent Opinions Of Independent Directors On Matters Related To The First Meeting Of The Fifth Board Of Directors
- Lepu Medical: Announcement of Resolutions of the First Meeting of the Fifth Supervisory Board
- Lepu Medical: Announcement of Resolutions of the First Meeting of the Fifth Board of Directors
- Lepu Medical: Haitong Securities Co., Ltd.'s Listing Sponsorship Of The Company's Public Offering Of Convertible Corporate Bonds
- Lepu Medical: Public Offering of Convertible Corporate Bonds Listing Announcement
- Lepu Medical: Beijing Zhonglun Law Firm's Legal Opinion on the Public Offering of Convertible Corporate Bonds by the Company's Growth Enterprise Market on the Shenzhen Stock Exchange
- Lepu Medical: Legal Opinion of the First Extraordinary Shareholders' Meeting in 2020
- Lepu Medical: Announcement of Resolutions of the First Extraordinary General Meeting of Shareholders in 2020
- Lepu Medical: Announcement on Signing Tripartite Supervision Agreement on Raised Funds
- Lepu Medical: Announcement on the Implementation of the First Phase of Employee Stock Ownership Plan
- Lepu Medical: Announcement of the Results of the Public Issuance of Convertible Corporate Bonds
- Lepu Medical: Notice on Convening the First Extraordinary Shareholders' Meeting in 2020
- Lepu Medical: Announcement on Election of Staff Supervisors of the Fifth Supervisory Board
- Lepu Medical: Announcement of the Results of Online Issuance of Convertible Corporate Bonds
- Lepu Medical: Statement of Nominee of Independent Director (3)
- Lepu Medical: Statement of Independent Director Nominee (1)
- Lepu Medical: Statement of Independent Director Candidate (Gan Liang)
- Lepu Medical: Statement of Independent Director Candidate (Zhi Yi)
- Lepu Medical: Statement of Independent Director Candidate (Cao Lu)
- Lepu Medical: Independent Opinions of Independent Directors on the Reelection of the Company's Board of Directors and the Selection of Candidates for the Fifth Board of Directors
- Lepu Medical: Announcement of Resolutions of the 27th Meeting of the Fourth Supervisory Board
- Lepu Medical: Announcement of Resolutions of the 30th Meeting of the Fourth Board of Directors
- Lepu Medical: Announcement of Online Success Rate and Priority Placement of Convertible Corporate Bonds
- Lepu Medical: Announcement of Public Issuance of Convertible Corporate Bonds
- Lepu Medical: Haitong Securities Co., Ltd.'s Issuance Letter Of Sponsorship For The Public Issuance Of Convertible Corporate Bonds By The Gem
- Lepu Medical: Public Issuance of Convertible Corporate Bond Credit Rating Report
- Lepu Medical: Beijing Zhonglun Law Firm's Supplementary Legal Opinion on the Public Issuance of Convertible Corporate Bonds by the Company's Growth Enterprise Market (5)
- 2019-091 Announcement on the Company's Development of Foreign Exchange Hedging Business
- Lepu Medical: 2018 Annual Audit Report
- Lepu Medical: Beijing Zhonglun Law Firm's Supplementary Legal Opinion on the Public Issuance of Convertible Corporate Bonds by the Company's Growth Enterprise Market (5)
- Lepu Medical: Beijing Zhonglun Law Firm's Supplementary Legal Opinion on the Public Issuance of Convertible Corporate Bonds by the Company's Growth Enterprise Market (4)
- Lepu Medical: Beijing Zhonglun Law Firm's Supplementary Legal Opinion on the Public Issuance of Convertible Corporate Bonds by the Company's Growth Enterprise Market (3)
- Lepu Medical: Beijing Zhonglun Law Firm's Supplementary Legal Opinion on the Public Issuance of Convertible Corporate Bonds by the Company's Growth Enterprise Market (1)
- Investor Relations
- Quarterly Reports
- Semi-annual Reports
- Annual Reports
- Annual Dividends Notice
- Financial Reports
- e-IFU
- Contact Us